AI assistant
Cigna Group — Director's Dealing 2025
Mar 5, 2025
29918_dirs_2025-03-04_1e493d19-ebe5-411a-b981-517f9131cdec.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cigna Group (CI)
CIK: 0001739940
Period of Report: 2025-02-28
Reporting Person: Kates Jamie G (Chief Accounting Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-02-28 | Common Stock, $.01 Par Value | A | 405.0000 | $0.0000 | Acquired | 1621.0000 | Direct |
| 2025-02-28 | Common Stock, $.01 Par Value | A | 246.0000 | $0.0000 | Acquired | 1867.0000 | Direct |
| 2025-02-28 | Common Stock, $.01 Par Value | F | 51.0000 | $305.8600 | Disposed | 1816.0000 | Direct |
| 2025-02-28 | Common Stock, $.01 Par Value | F | 130.0000 | $305.8600 | Disposed | 1686.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-02-28 | Employee Stock Option (Right to Buy) | $305.8550 | A | 871.0000 | Acquired | 2035-02-28 | Common Stock, $.01 Par Value (871.0000) | Direct |
Footnotes
F1: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2022-2024 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.
F2: These restricted shares vest in three equal annual installments beginning March 1, 2026.
F3: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.
F4: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.
F5: This option vests in three equal annual installments beginning March 1, 2026.